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Optical coherence tomography (OCT) uses light interference patterns to produce a cross-sectional image of the retina. It is capable
of measuring the unmyelinated axons of the retinal ganglionar cells as they converge on the optic disc. In a disease like multiple
sclerosis(MS),inwhichaxonallosshasbeenidentiﬁedasanimportantcauseofsustaineddisability,itmayproveaninvaluabletool.
OCT has demonstrated that axonal loss occurs after each episode of optic neuritis and that the degree of axonal loss is correlated
to visual outcomes. Furthermore, axonal loss occurs in MS even in the absence of inﬂammatory episodes, and the degree of this
loss is correlated with the duration of the disease process, with more thinning as the disease advances and in progressive forms.
Thus, OCT retinal nerve ﬁber layer measurements may represent an objective outcome measure with which to evaluate the eﬀect
of treatment.
1.Introduction
The optic nerve as it leaves the eye is the only tissue
composed of unmyelinated axons which can be imaged
directly. The retinal nerve ﬁber layer (RNFL) is made up of
theaxonsoftheretinalganglionarcellsthatconveythevisual
information from the retina to the lateral geniculate nucleus;
until they exit the eye, they do not acquire the protective
myelin sheath. This extraordinary circumstance allows us
to study the inﬂuence on isolated axons of several diseases.
Ganglionar cells and their axons, besides being the main
retinal component around the optic nerve (90% of retinal
thickness) are also representative at the macula (30–35%).
Both time-domain and spectral-domain optical coher-
ence tomographies (OCT) use light interference patterns to
produce a tomogram, or cross-section, through the layers
of the retina. From this information, the OCT software
constructs a two-dimensional (time-domain, TD-OCT) or
three-dimensional (spectral-domain, SD-OCT) image of the
retina and the optic nerve and is capable of measuring the
diﬀerent layers of the retina with a margin of error of 4–
6µm. The reproducibility of RNFL and macular measures
has been found to be excellent with SD-OCT in multiple
sclerosis [1]. Multiple studies have provided information on
the normal values for the RNFL thickness and have reported
the RNFL loss that occurs after diﬀerent pathologies that
aﬀect the optic nerve.
Axonal loss, in contrast to demyelination, is not
reversible and is therefore an important cause of sustained
disability. In patients diagnosed with multiple sclerosis,
it has been demonstrated that axonal loss occurs in the
early stages of the disease. This is one of the reasons that
support the early use of neuroprotective drugs. Monitoring
axonal loss has become a priority in multiple sclerosis and2 Multiple Sclerosis International
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Figure 1: Fundus photograph, visual ﬁelds, and optical coherence tomography of a 30-year-old man who consulted due to ocular pain and
visual loss in his left eye for two weeks. Optical coherence tomography shows an increased retinal nerve ﬁber layer thickness in his left eye
due to optic nerve edema.
OCT as a sensitive, precise, and reproducible technique is
acquiring increasing importance for both neurologists and
ophthalmologists [2].
2.IsolatedAcuteOpticNeuritis
Optic neuritis is one of the manifestations of multiple
sclerosis; it has been described as the second most frequent
mode of presentation. The Optic Neuritis Treatment Trial
(ONTT) has shown us that a patient diagnosed with a ﬁrst
episode of optic neuritis has a risk of 50% of developing
multiplesclerosisinthefollowing15years.Theriskincreases
to72%inthosepatientswithatleastonedemyelinatedlesion
on magnetic resonance imaging (MRI) and decreases to 25%
in those without lesions [3]. However, these data are not
applicable to all patients, for example, in Asian populations
MRI lesions are less frequently encountered [4].
2.1. Acute Changes in Anterior Optic Neuritis. Optical coher-
ence tomography has a high sensitivity for detecting acute
optic nerve oedema in anterior optic neuritis (Figure 1). Our
study group performed one of the ﬁrst prospective studies
evaluating TD-OCT in acute optic neuritis. Twenty-three
patients underwent a complete ophthalmological evaluation,
including visual acuity (VA) measurement, automated static
perimetry, and OCT at onset and periodically for six
months. We found a statistically signiﬁcant increase in initial
mean RNFL thickness in anterior forms (166.30µm, SD
34.87µm) as compared to retrobulbar neuritis (98.60µm,
SD 21.58µm), Doctoral thesis: “Study of optic neuritis with
optical coherence tomography.”
2.2. Axonal Loss. Following an initial episode of optic
neuritis, OCT can detect axonal loss as a thinning of the
RNFL, occurring mainly in the ﬁrst three to six months
(Figure 2). After this period, axonal loss stabilizes [5–7].
RNFL measurements obtained within the ﬁrst eight weeks
of optic neuritis may reﬂect the extent of optic disc and
RFNL edema due to an acute bulbar or retrobulbar injury;
whereas RNFL values obtained 3 or more months after ON
mayindicatetheextentofaxonalinjuryreferabletotheacute
inﬂammatory event [7].
Prospective studies estimate that there is a 20 to 25%
loss in the RNFL thickness when compared to the fellow
unaﬀected eye (Table 1)[ 5, 6, 8] .T h ed e c r e a s ei sg r e a t e r
in Asian patients whose visual function is damaged more
severely [4]. Most studies have been unable to demonstrate
a signiﬁcant thinning of the RNFL of the fellow eyes when
compared to healthy controls [8–11].
Axonal loss aﬀects diﬀusely the whole peripapillary
RNFL, although the temporal quadrant is often the most
aﬀected. This loss may be detected as soon as two months
after the event, when compared to the fellow eye and
healthy controls [4, 7, 8]. Temporal thickness decreasesMultiple Sclerosis International 3
Table 1: Comparison of RNFL thickness (µm) between both eyes of patients who have suﬀered unilateral optic neuritis and healthy control
subjects. Values are expressed as mean (standard deviation).
Patients ON eye Fellow eye Control
Outteryck et al.[19] Non-MS 92.27 (12.82) — 98.71 (9.08)
Grazioli et al. [28] MS 81.7 (19.2) 93.6 (15.3) —
Klistorner et al. [9] MS and non-MS 84.5 (15. 1) 103.8 (10.8) 104.0 (9.2)
Siger et al. [22] MS 83.92 (17.63) 91.08 (19.3) —
Costello et al. [7] Non-MS 86.1 101.6 —
Noval et al. (data not published) MS and non-MS 84.95 (23.45) 103.40 (15.27) 105.5 (10.51)
Fisher et al. [10] MS 85 (17) 96 (14) 105 (12)
Costello et al. [5] Non-MS 77.5 (29.87) 99.8 (32.5) —
Trip et al. [11] MS and non-MS 68.7 (18.8) 94.6 (14.9) 102.9 (14.6)
Parisi et al. [12] MS 59.79 (10.80) 82.73 (10.73) 111.11 (11.42)
MS: multiple sclerosis.
NON: MS healthy subjects.
ON: optic neuritis.
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Figure 2: Patient who developed retrobulbar neuritis in his right
eye as an initial clinically isolated syndrome. In only three months,
axonal loss can be detected in the eye that suﬀered the neuritis.
between 25 and 34% [5, 8, 12]. This reﬂects a predominant
aﬀectation of the papillomacular bundle, which conveys the
information from the fovea, the central macular structure
mainly responsible for detailed visual and color functions.
Therefore, macular volume is also mildly reduced in eyes
that have suﬀered optic neuritis [13], especially in the nasal
sectors of the macula [14]. Cutoﬀ points of 51.5µm for the
temporal RNFL thickness and 88.8µm for the average RNFL
thickness have shown the highest sensitivity (0.72 and 0.60,
resp.) and speciﬁcity (0.95 and 0.97, resp.) for diﬀerencing
optic neuritis eyes from control eyes [8].
The optic nerve can become pale after an episode of
optic neuritis. This pallor can be diﬀuse or located in the
temporalquadrantandreﬂectstheRNFLlossdetectablewith
OCT. Because the temporal quadrant of the optic disc is
relatively thinner than other quadrants, even diﬀuse atrophy
maybeperceivedonlyastemporalpalloronexam.Ourstudy
group also found a mild increase in the cup to disc ratio of
approximately 0.1 to 0.2 when compared to the fellow eye, in
accordance with previous clinical observations [15, 16].
2.3. Visual Prognosis. Since RNFL loss after an episode of
optic neuritis stabilizes after six months, most studies that
analyze the relationship between axonal loss and visual
outcomeareperformedatorafterthistimepoint.Costelloet
al. found that patients with incomplete visual recovery after
optic neuritis suﬀer a greater RNFL loss and through regres-
sionanalysisobtainedathresholdofRNFLthickness(75µm)
belowwhichRNFLmeasurementspredictedpersistentvisual
dysfunction. This ﬁnding could be interpreted as a threshold
eﬀect whereby changes in RNFL thickness above 75µma r e
associated with minimal and clinically insigniﬁcant changes
in visual ﬁeld threshold sensitivity [5, 7]. In Costello’s study,
for RNFL values below 75µm, a 10µmd e c r e a s ei nR N F L
thickness predicted a decrease of 6.83dB in visual ﬁeld mean
deviation scores among aﬀected eyes [7].
Visual ﬁelds represent a subjective method of measuring
visual function, which requires active collaboration and
attentiveness from the patient. Visual ﬁelds usually improve
afteraﬁrstepisodeofopticneuritistonormalornearnormal
levels. However, OCT often reveals subclinical permanent
axonal damage, which may not be reﬂected by subjective
explorations. Thus, 60% of patients with normal visual ﬁelds
in our study had abnormal RNFL thickness measurements
by OCT at the six-month visit [6]. Pueyo et al. enrolled
40 patients with multiple sclerosis who had normal VA
and visual ﬁelds in a prospective cohort. Although the for-
mer examinations were normal, signiﬁcant diﬀerences with
healthy subjects were observed in Ishihara color tests and in
most RNFL measurements provided by OCT. Comparisons
with the normative database showed RNFL defects in 12 eyes
(30%) [17].
Low contrast letter acuity (LCLA) is being increasingly
usednowasavisualoutcomemeasureinMSandONstudies.
Talman et al. demonstrated that progressive RNFL thinning
occurs as a function of time in MS and is associated with
clinically signiﬁcant visual loss by low-contrast letter acuity.
They found that visual loss by the 2.5% contrast chart was4 Multiple Sclerosis International
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Figure 3: Patient who suﬀered a motor clinical isolated syndrome and fulﬁlled Barkhof’s magnetic resonance imaging criteria. Optical
coherence tomography shows a decreased retinal nerve ﬁber layer in both eyes (more intense in the right eye) even without a history of optic
neuritis.
signiﬁcantly associated with RNFL thinning. Scores from
the 1.25% contrast chart, however, correlated less well with
RNFL loss [18]. Fisher et al. found that lower visual function
scores were associated with reduced average overall RNFL
thickness. For every 1-line change in low-contrast letter
acuity and in contrast sensitivity scores, RNFL thickness
diﬀerences of 4µm on average were noted, accounting for
age. Spearman rank correlations between overall average
RNFL thickness and visual function scores were highly
signiﬁcant yet modest in magnitude, suggesting that visual
dysfunction may occur in some patients in the absence of
(or perhaps in advance of) RNFL axonal loss (Spearman r
[rs] = 0.33 and P<. 0001 for low-contrast letter acuity,
rs = 0.31 and P<. 0001 for contrast sensitivity, rs = 0.26
and P = .0005 for high-contrast VA) [10].
Thus, both LCLA and RNFL thinnings are being intro-
duced as surrogate markers for disability in MS trials.
However, it should be taken into account that some patients
may present with visual loss even in the presence of a
preserved RNFL thickness, while on the other hand patients
with decreased RNFL thickness may not present severe
dysfunction if nerve ﬁber loss does not aﬀect the papillo-
macularbundle.Furthermore,patientswithvisuallossadapt
with time to their scotomas, so that visual function may
improve as they learn to manage with their limitations.
3. Optical Coherence Tomography in Patients
withClinicallyIsolatedSyndrome
The development of a clinically isolated syndrome (CIS)
represents the earliest clinical stage of multiple sclerosis.
Outteryck et al. studied 56 patients with CIS, 18 with optic
neuritis, and 38 without it. Two-thirds of the patients had
dissemination in space according to the Barkhof criteria.
All of the patients had a normal overall RNFL thickness.
However, 14 patients (25%) and 7 controls (22%) had RNFL
atrophyinatleast1quadrant,accordingtotheOCTdatabase
(Figure 3). There was no link between atrophy in 1 or more
quadrantsoftheRNFLanddisseminationinspaceaccording
to the Barkhof criteria at initial MRI, nor with multifocal
presentation, alteration of visual evoked potentials, or devel-
opment of multiple sclerosis after 6 months according to theMultiple Sclerosis International 5
Table 2: Comparison of RNFL thickness (µm) between both eyes of patients diagnosed of multiple sclerosis who have suﬀered unilateral
optic neuritis and healthy control subjects.
MS with ON MS without ON Control
Siepman et al. [13] 72.2 (14.4) 89.5 (14.2) —
Khanifar et al.∗ [14] 83.0 (14.0) 90.5 (13.2) 97
Costello et al. [23] 79.5 (18.8) 97.0 (14.3) —
Bock et al. [27] 86.2 (16.2) 97.0 (13.1) 105.2 (9.4)
Quelly et al. [30] 78.01 (17.43) 95.24 (11.64) —
Merle et al. [31] 80.81 (18.4) 96.7 (15.8) 106 (12.2)
Oreja-Guevara et al. [32] 76.42 (16.87) 89.45 (17.68) —
Frohman et al. [33] 70.3 (13.4) 101.8 (6) 101.9 (8.9)
Burkholder et al. [21] 85.7 (19.0) 95.6 (14.5) 104.5 (10.7)
Spain et al. [34] 75.81 90.93 —
Siger et al. [22] 83.92 (17.63) 94.38 (15.0) 100.3 (12.1)
Pueyo et al. [35] 84.46 94.20 104.97
Zaveri et al. [36] 81.8 (19.3) 95.6 (15.0) 104.6 (10.3)
Pulicken et al. [37] 84.2 (14.7) 95.9 (14) 102.7 (11.5)
Gundogan et al. [20] — 107.6 (16.3) 110.9 (10.3)
Cheng et al. [38] 76.12 (14.92) 96.45 (11.73) —
Fisher et al. [10] 85 (17) 96 (14) 105 (12)
∗Heidelberg Spectralis. Value for normals taken from normative database.
MS: multiple sclerosis.
ON: optic neuritis.
revised McDonald criteria [19]. However, the relationship
between RNFL thinning in CIS and progression to MS is still
unclear,sinceonlylong-termfollowupwilldetermineifthese
changes are clinically relevant.
4. MultipleSclerosis
In the absence of optic neuritis, retrograde trans-synaptic
retinal ganglion cell degeneration due to multiple sclerosis
lesions within the posterior optic pathways could cause
RNFL loss. Progressive axonal loss could also explain the
RNFL thinning found in eyes of patients with multiple
sclerosis without a history of optic neuritis (Table 2)[ 14].
In these eyes, mean RNFL loss is milder (7.08µm) than in
eyes that have suﬀered optic neuritis (20.38µm) [2]. Some
studies have only found a signiﬁcant diﬀerence in eyes with
and without optic neuritis for the temporal quadrant [20].
On average, 10µmd i ﬀerences in RNFL thickness are
associated with 0.20mm3 reductions in total macular vol-
ume. Eyes of patients with multiple sclerosis both with
and without optic neuritis showed similar degrees of total
macular volume reduction [21].
A moderate correlation has been found between RNFL
thickness and the time from diagnosis of multiple sclerosis
[11, 14, 22, 23]. However, the correlation with neurological
disability quantiﬁed by the Expanded Disability Status
Scale (EDSS) is less consistent: some authors have found
a signiﬁcant correlation between the EDSS and RNFL
thickness [15, 22, 24, 25], while others have not [17, 26].
The strongest correlation was found in relapsing remitting
MS (RRMS) [23]. The diﬀerences between these studies
may be due to diﬀerences in the neurological status among
study populations. It has been proposed that OCT may be
more optimally used in little or moderately aﬀected patients
[13, 23].
RNFLthinningisgreaterwhenmultiplesclerosispatients
suﬀer an optic neuritis [21, 24], and more pronounced in
the temporal quadrant (Table 2)[ 27]. No diﬀerences were
detected between unaﬀected eyes of patients with multiple
sclerosis with or without an eye aﬀected of optic neuritis
[22, 27]. When the RNFL is measured in patients who have
suﬀered optic neuritis, the thinning is greater in patients
with multiple sclerosis than when it constitutes a clinical
isolated syndrome, and the diﬀerence is signiﬁcant for
the temporal quadrant [23]. This suggests that the disease
process underlying multiple sclerosis increases the damage
produced by an inﬂammatory episode.
4.1. Macular Edema. Optical coherence tomography has
become the most useful tool for the diagnosis of macular
edema. This is not a common isolated manifestation;
however, it could appear in multiple sclerosis patients with
intermediate uveitis or as a side eﬀect of therapies.
4.2. Recurrent Episodes of Optic Neuritis in Patients with
Multiple Sclerosis. Costello et al. compared eyes with isolated
optic neuritis to eyes with recurrent episodes of patients
with diﬀerent forms of MS and found an additional thin-
ning when the inﬂammation recurs [23]. They conclude
that the majority of patients may recover visual function
after an isolated optic neuritis event because they do not
suﬀer enough axonal damage to result in permanent visual
impairment. Patients with severe or recurrent optic neuritis,
however, may be at a greater risk of losing so many axons6 Multiple Sclerosis International
Table 3: Comparison of RNFL thickness (µm) among diﬀerent types of multiple sclerosis.
RRMS SPMS PPMS Control
Albrecht et al. [39] 86.91 (21.51) 70.57 (16.76) 80.45 (17.76) 103.4 (10.96)
Henderson et al. [40] Non-ON Not supplied 88.4 (10.9) Not supplied Not supplied
Pulicken et al. [37] 94.4 (14.6) 81.8 (15.6) 88.9 (13.3) —
RRMS: recurrent remittent multiple sclerosis.
SPMS: secondary progressive multiple sclerosis.
PPMS: primary progressive multiple sclerosis.
that they fall under the threshold required for complete
visual recovery, thus increasing the likelihood that they will
experience persistent visual defects [23].
4.3. Relationship with MRI Findings. Magnetic resonance
image ﬁndings are currently considered the most sensitive
and reliable markers for assessing inﬂammatory and axonal
pathology in patients with multiple sclerosis. Conventional
techniques are designed to be largely sensitive to inﬂamma-
tion (T2-weighted lesions) and not speciﬁcally reﬂect axonal
damage with only modest correlation with clinical disability
[25]. Alternatively diﬀuse brain atrophy has been linked with
disability progression in multiple sclerosis [25]. Signiﬁcant
associations have been shown between the RNFL thickness
and several MRI ﬁndings characteristic of brain atrophy:
(i) brain parenchymal fraction (which computes the
volumes of various intracranial compartments and
total brain parenchyma) [22, 25, 28],
(ii) diﬀusion tensor imaging values [29],
(iii) gray matter [22, 24] and white matter volume [24],
(iv) increase in cerebrospinal ﬂuid volume [25],
(v) magnetization transfer ratio [29],
(vi) T1-lesion volumen [22].
Frohman et al. studied twelve patients with multiple
sclerosis and found that low contrast visual acuity, RNFL
thickness, and optic nerve radius were the variables with
thehighestpredictivevalueindiscerningdiﬀerencesbetween
healthy controls and patients. Both the radius of the aﬀected
eyes and its fractional anisotropy predicted the RNFL of
the aﬀected eye; however, the RNFL thickness was the only
independent predictor of lower contrast sensitivity. T1 and
T2 lesion volumes, measures of optic nerve atrophy, and
measures of grey matter atrophy were related to RNFL
thickness, however, they explained only about 20% of
variance [29].
In multiple sclerosis patients without optic neuritis,
axonal loss seems to correlate better with MRI parameters
than in those that have suﬀered optic neuritis [22]. RNFL
thickness correlates with brain atrophy more strongly in
RRMS than in secondary progressive multiple sclerosis
(SPMS). This might be due to a basement eﬀect in the
progressive group, in which RNFL or brain tissue may
have reached their lowest levels so that further damage is
almost impossible. Another possibility is that most patients
with SPMS have clinical decline due to cumulative spinal
cord disease rather than accumulation of brain disease [25].
Macular volume does not correlate with MRI features [25].
4.4. Types of Multiple Sclerosis. There seem to be diﬀerent
patterns of axonal loss among the diﬀerent types of mul-
tiple sclerosis according to their clinical course (Table 3).
Henderson et al. studied patients with progressive forms of
multiple sclerosis, excluding those who had suﬀered optic
neuritis in both eyes. Axonal loss was signiﬁcant compared
to controls, for the mean RNFL in the SPMS group and for
the temporal quadrant in both progressive forms (53.6µm,
SD 13.2µm and 63.7µm, SD 14.6µm, for SPMS and primary
progressive (PPMS] types, resp.). The only diﬀerence found
between both groups was the thinner temporal quadrant in
the SPMS group [40]. These results could be explained by
subclinical optic neuritis attacks suﬀered by SPMS patients
in the remittent recurrent phase, by diﬀerences in the time
from diagnosis that existed between both groups or due to
distinctive preferences in the nervous system aﬀected in each
form [40].
Pulicken et al. also found RNFL thinning in the progres-
sive forms, which was more pronounced than in patients
with RRMS [37], and Siepman et al. did not ﬁnd signiﬁcant
diﬀerences when comparing eyes of patients with PPMS and
RRMS [13]. Therefore, it seems that during the progressive
phase progressive axonal loss also develops, being more
pronounced in the SPMS type [37].
Costelloetal.studiedpatientswhohadhadisolatedoptic
neuritis (without a diagnosis of MS) and patients who had
had an episode of neuritis and were already diagnosed with
RRMS, SPMS, or PPMS. Optic atrophy was more severe
in the secondary progressive group with more pronounced
diﬀerences in the temporal quadrant. The diﬀerences among
multiple sclerosis types are more diﬃcult to appreciate in
eyes without optic neuritis [23].
Total macular volumes also diﬀered between multiple
sclerosis disease subtypes, with lower values seen in SPMS
[mean (SD], 6.25(0.52]mm3) than in PPMS (mean (SD),
6.57(0.50]mm3)[ 21].
4.5. Visual Prognosis. Multiple sclerosis patients have worse
contrast sensitivity and visual ﬁelds if they have suﬀered an
episode of optic neuritis, in accordance with their decreased
RNFL thickness, than if they just have subclinical axonal loss
[10, 32, 41].
Visual prognosis after an episode of optic neuritis is
good, since approximately three out of four patients retain
a visual acuity of 20/20 after 15 years [42]. Visual acuityMultiple Sclerosis International 7
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Figure 4: Patient withmultiplesclerosisand severebilateral RNFLthinningwith historyofopticneuritis.SD-optical coherence tomography
analysis found no further loss during a year.
after an episode of neuritis is similar in patients already
diagnosed with multiple sclerosis to patients in whom it is an
isolated manifestation. However, visual ﬁeld mean deviation,
a parameter that measures light sensibility depression, is
slightly lower for multiple sclerosis patients [32], probably
because visual acuity is less sensitive to asses visual function
in multiple sclerosis patients than other examinations, such
as color vision, stereopsis, or contrast sensitivity [8, 43].
Visual acuity in patients with multiple sclerosis with-
out optic neuritis does not diﬀer from healthy controls.
However, when tests that explore spatial (Sloan and Pelli-
Robson charts) and temporal (frequency doubling tech-
nology perimetry) contrast sensitivity are employed, visual
function is found to be worse in multiple sclerosis patients
whencomparedtocontrolsubjects[31].Intheirstudy,Merle
et al. found that eyes with a previous history of optic neuritis
presented an important decrease in RNFL thickness, which
was correlated with the results of all the visual function tests
performed, including VA [31].
Visual ﬁelds may be normal even if RNFL loss is
detected: Cheng et al. found no perimetric defects in 4%
patients with mean RNFL atrophy and in 18% with at
least sectorial atrophy according to normative data [38].
Disagreement between RNFL thickness and visual ﬁelds
is probably inﬂuenced by cognitive dysfunction or slowed
reaction times during subjective ﬁeld testing, which can
interfere with decision-making, in patients with multiple
sclerosis and also by central visual pathway damage that
does not result in retrograde degeneration. However, when
functional loss is worse than −10dB, the authors concluded
that it is better to use mean deviation for monitoring disease
progression, because RNFL loss has almost reached a plateau
at approximately 60µm( Figure 4)[ 38].
L o w e rR N F Lv a l u e sh a v eb e e nc o r r e l a t e dw i t hr e d u c e d
visual acuity and mean deviation. Every 10µmd e c r e a s e
in RNFL correlated with a 5.8dB decrease in visual ﬁeld
sensitivity and a 0.46 reduction in visual acuity for RNFL
values below 75µm[ 23].
4.6. Evolution. Longitudinal studies have been performed to
assess changes in RNFL thickness. Talman et al. followed
299 patients with multiple sclerosis for at least six months,
with a median followup of 18 months, ranging between 6
months and four and a half years. They found that each
year of followup was associated on average with a 2.0µm
decreases in RFNL thickness. This rate of axonal loss was
similar in patients with and without a history of optic
neuritis. Eyes with visual loss by low-contrast letter acuity
and VA (measured with an ETDRS chart and concerted to
logMAR for analysis) had greater degrees of RNFL thinning
during followup compared to those without visual changes.
RNFL thinning was also associated with progressive changes
in neurological impairment measured by the EDSS [18].
Sepulcre et al. found a decrease in average RNFL thickness of
4.8µminpatientsafter2years.Theyfoundthatpatientswith
more active disease have a thinner temporal quadrant RNFL8 Multiple Sclerosis International
Table 4: Comparison of RNFL thickness (µm) between multiple sclerosis and neuromyelitis optica.
NMO ON eye NMO fellow eye MS ON eye MS fellow eye Control
Nakamura et al. [45] 63.84 (23.47) 106.36 (14.55) 84.28 (14.18) 109.45 (12.78) —
Naismith et al. [26] 54.8 (3.7) — 76.5 (2.4) — —
Merle et al. [46] 65.44 (24.19) 83.85 (24.12) 106.24 (12.46)
MS: multiple sclerosis.
NMO: neuromyelitis optica.
compared with stable patients. Patients with new relapses
during followup had a thinner RNFL in the temporal quad-
rant than relapse-free patients by the end of the study [24].
Garc´ ıa-Mart´ ın et al. enrolled 81 patients with a diagnosis of
deﬁnedmultiplesclerosis:31ofthepatients(38.3%)received
no speciﬁc treatment, whereas the other 50 patients (61.7%)
were treated with interferon beta. Most studied eyes (75.3%)
were from patients without a history of optic neuritis.
Statisticallysigniﬁcantdiﬀerenceswereobservedbetweenthe
baseline and 1-year examinations in all the RNFL thickness
measurements and macular volume and in VA (logMAR),
whereas perimetry results revealed no diﬀerences between
treated and untreated patients. The greatest decrease was
found in the average and the inferior OCT RNFL thickness
(of 3%), with a baseline mean of 90.46µm and 115.46µm
versus 85.96µm and 109.12µm at the 1-year followup,
respectively, No correlation was found between the 1-year
change in EDSS and RNFL measurements. They concluded
that axonal loss in the optic nerve of patients with multiple
sclerosis is far greater than that which occurs in healthy
subjects, regardless of the presence of a history of optic
neuritis [44].
5. NeuromyelitisOptica
Visual prognosis is much worse if optic neuritis occurs
in patients with neuromyelitis optica. Only one episode is
capable of producing legal blindness in almost one third of
patients and only about 45% of them completely recover
visual function [47]. An ischemic vascular mechanism has
been proposed in its pathogenesis to explain at least partially
its severity [48]. Ratchford et al. have suggested that an
RNFL thickness loss after an episode of optic neuritis of
more than 15µm may be considered a marker for this disease
instead of multiple sclerosis, together with the absence of a
visual improvement of at least two lines [49]. Naismith et al.
estimatedthatforevery1µmdecreaseintheRNFLthickness,
the odds of being diagnosed with NMO increased by 8%
[26]. Several reports have conﬁrmed that axonal loss after an
episodeofopticneuritisinpatientswithneuromyelitisoptica
is greater than in patients with multiple sclerosis (Table 4)
[45, 46]. This diﬀerence persisted even after adjusting the
RNFL for visual outcome [26]. It has also been shown
that the superior and inferior quadrants are more intensely
aﬀected after NMO, so that the pattern of the RNFL loses
its characteristic humps [26, 45]. Recurrent episodes of optic
neuritis lead to further RNFL loss [45].
The mean RNFL thickness of the unaﬀected fellow eye
in NMO has been found to be greater than the unaﬀected
multiple sclerosis eyes. This sparing of the unaﬀected felloe
eye in NMO compared to MS may be explained by a more
common occurrence of subclinical optic neuritis in multiple
sclerosis: axonal attrition in multiple sclerosis independent
of optic neuritis or an increased predilection of multiple
sclerosis lesions in the optic chiasm or tracts [26].
As in multiple sclerosis, mean RNFL is correlated with
best-corrected visual acuity. Studies agree on the fact that
there is a critical value of RNFL thickness below which
further decreases of the RNFL lead to incomplete visual
recovery. This critical value has been set at 71.41µm[ 45].
Below 50–52µm, vision drops to ≤20/100 [26, 46].
In a retrospective study, Nakamura et al. evaluated the
eﬀects of high dose intravenous methyl-prednisolone on the
outcomes after optic neuritis in patients with neuromyelitis
optica. Early treatment, especially within 3 days after onset,
ledtoagreaterprobabilityofpreservinganRNFL>71.41µm
(the cutoﬀ point in this study for preserving a visual acuity
>20/20) [45].
Even if RNFL loss is greater in NMO as compared to
MS, at each level of visual function there was a considerable
overlap in OCT measures, limiting the role of OCT to
diﬀerentiate the two conditions on an individual basis
(Figure 5)[ 50].
6. Conclusions
(i) Opticalcoherencetomographyconﬁrmsthepresence
of optic disc edema in anterior neuritis, reﬂected as a
thickening of the RNFL.
(ii) Axonal atrophy develops after optic neuritis so that
six months after the event, the RNFL thickness
is predictive of visual and neurological disability.
However, it may be more optimally used in little or
moderately disable patients.
(iii) Optical coherence tomography can detect subclinical
axonal loss in patients with normal visual acuity and
visualﬁelds.Contrastsensitivityseemstobethemost
useful test to detect subtle visual impairment.
(iv) The temporal quadrant is the most vulnerable to the
disease process.
(a) Temporal RNFL thickness may be decreased as
soon as two months after the event.
(b) Reduced temporal thickness is often the only
sign that may diﬀerentiate multiple sclerosisMultiple Sclerosis International 9
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Figure 5: Teenager diagnosed of neuromyelitis optica who has suﬀered bilateral optic neuritis as well as myelitis. Although normative data
are not available, the retinal nerve ﬁber layer thickness measured with optical coherence tomography is extremely low.
patients from healthy subjects and between
primary and secondary progressive forms.
(c) It may provide important insights regarding
relapse related activity in multiple sclerosis
patients.
(v) During the progressive phases of multiple sclerosis,
axonal loss also occurs at the optic nerve; this axonal
loss is detected by OCT as RNFL loss and is greater in
the SPMS type.
(vi) When multiple sclerosis patients are followedup, an
approximate decrease of 2µm in RFNL thickness
is detected per year. Progressive changes seem to
correlate with changes in neurological impairment
measured by the EDSS.
(vii) Brain atrophy is at least moderately correlated to
RNFL thickness and multiple sclerosis patients have
decreased RNFL thickness even without a history of
optic neuritis. These results suggest that the RNFL
thinning reﬂects pathology that extends beyond local
injury to the optic nerve by optic neuritis.
A stronger correlation with MRI results is unlikely
since axons are not the only component of the brain
and because brain atrophy also reﬂects synaptic
changes, loss of myelin, gliosis, and changes in water
content.
(viii) Visual prognosis is much worse if optic neuritis
occurs in patients with neuromyelitis optica, which
leads to a more sever thinning of the RNFL when
compared to optic neuritis in multiple sclerosis
patients.
(ix) OCT thus seems to be a promising outcome measure
for neuroprotective trials. However, overall RNFL
thickness is not always directly correlated with visual
function and measuring both mean RNFL thickness
and temporal RNFL thickness (usually more related
to visual acuity) would require more patients to be
included into the studies. Furthermore, it may be
diﬃcult to distinguish axonal loss related to age with
axonal loss due to the disease process in MS. The
relationship between axonal loss and OCT is not
clear: future studies need to evaluate it.10 Multiple Sclerosis International
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